Free · 2 imports included
code🏥 Respiratory and Pulmonary Pharmacology ├── 📖 Chapter 1: Obstructive Lung Diseases and Related Pharmacology │ ├── 🔹 Emphysema and Chronic Bronchitis │ ├── 🔹 Asthma and COPD Pharmacology │ └── 🔹 Leukotriene Modifiers and Immunotherapy ├── 📖 Chapter 2: Infectious Respiratory Diseases and Treatment │ ├── 🔹 Sinusitis, Pertussis, and Pneumonia │ ├── 🔹 Tuberculosis and Influenza Treatment │ └── 🔹 RSV Prophylaxis and HAP/VAP Treatment ├── 📖 Chapter 3: Miscellaneous Respiratory Conditions and Pharmacology │ ├── 🔹 Antihistamines and Decongestants │ ├── 🔹 Cell Wall and Protein Synthesis Inhibitors │ └── 🔹 Fungal Infections and Lung Cancer Treatment
What this chapter covers: This chapter delves into the pathophysiology and pharmacological management of obstructive lung diseases such as emphysema, chronic bronchitis, asthma, and COPD. It emphasizes the mechanisms of action of bronchodilators, anti-inflammatory agents, leukotriene modifiers, and immunotherapies. The chapter aims to equip students with the knowledge to understand and treat these common respiratory conditions effectively.
| Drug/Class | Mechanism | Uses | Side Effects |
|---|---|---|---|
| Albuterol (SABA) | Stimulates adenylate cyclase, increasing cAMP, leading to bronchodilation. | Acute asthma exacerbations, COPD | Tachycardia, tremor, hypokalemia |
| Salmeterol (LABA) | Long-acting beta-2 agonist; stimulates adenylate cyclase. | Maintenance therapy for asthma and COPD (with inhaled corticosteroid) | Tachycardia, tremor |
| Ipratropium | Muscarinic antagonist; blocks M3 receptors, preventing bronchoconstriction. | COPD, asthma | Dry mouth, blurred vision |
| Theophylline | Inhibits phosphodiesterase (PDE), increasing cAMP levels. | Asthma, COPD | Narrow therapeutic index; arrhythmias, seizures |
| Fluticasone | Corticosteroid; increases lipocortin synthesis, inhibiting phospholipase A2. | Asthma, COPD | Oral candidiasis, dysphonia |
| Montelukast | Leukotriene receptor antagonist; blocks cysLT1 receptor. | Asthma | Headache, neuropsychiatric effects |
| Omalizumab | Anti-IgE antibody; reduces free IgE levels. | Severe allergic asthma | Anaphylaxis |
Question: A 55-year-old male with COPD presents to the emergency department with increased shortness of breath. Which of the following medications would provide the most rapid relief of his symptoms? A) Fluticasone B) Salmeterol C) Albuterol D) Montelukast
Answer: C Explanation: Albuterol is a short-acting beta-2 agonist (SABA) that provides rapid bronchodilation, making it the most appropriate choice for immediate relief of acute symptoms. Fluticasone is a corticosteroid and is used for long-term control. Salmeterol is a long-acting beta-2 agonist (LABA) and is not suitable for acute relief. Montelukast is a leukotriene receptor antagonist and is used for maintenance therapy.
❌ Mistake 1: Prescribing a LABA (e.g., Salmeterol) as monotherapy for asthma. ✅ How to avoid: Always combine LABAs with inhaled corticosteroids in asthma patients to reduce the risk of exacerbations and mortality.
❌ Mistake 2: Forgetting to rinse the mouth after using inhaled corticosteroids. ✅ How to avoid: Educate patients on the importance of rinsing their mouth with water after each use to prevent oral candidiasis (thrush).
Use a table to compare and contrast the onset and duration of action of different bronchodilators (SABAs, LABAs, anticholinergics) to understand when each is most appropriate.
What this chapter covers: This chapter addresses the pharmacological management of various infectious respiratory diseases, including sinusitis, pertussis, pneumonia (atypical, nosocomial, community-acquired), tuberculosis, and influenza. It focuses on appropriate antibiotic selection, antiviral therapies, and prophylactic measures. The chapter aims to provide a practical guide to treating these common infections.
| Condition/Disease | Causative Agent(s) | First-Line Treatment | Alternative Treatment |
|---|---|---|---|
| Sinusitis | Streptococcus pneumoniae, Haemophilus influenzae | Amoxicillin or Amoxicillin/Clavulanate | Doxycycline or Fluoroquinolones (if penicillin allergy) |
| Pertussis | Bordetella pertussis | Macrolides (Azithromycin, Clarithromycin) | TMP/SMX |
| Atypical Pneumonia | Mycoplasma pneumoniae, Chlamydophila pneumoniae, Legionella pneumophila | Macrolides, Doxycycline, Fluoroquinolones | |
| CAP (Outpatient) | Streptococcus pneumoniae, Mycoplasma pneumoniae, Haemophilus influenzae | Amoxicillin, Doxycycline, or Macrolides | |
| CAP (Inpatient) | Streptococcus pneumoniae, Legionella pneumophila, Haemophilus influenzae | Beta-lactam + Macrolide or Fluoroquinolone | |
| Tuberculosis | Mycobacterium tuberculosis | RIPE therapy (Rifampin, Isoniazid, Pyrazinamide, Ethambutol) | Moxifloxacin (for resistant cases) |
| Influenza | Influenza A and B viruses | Oseltamivir, Zanamivir, Baloxivir |
Question: A 68-year-old male presents with cough, fever, and shortness of breath. Chest X-ray reveals a right lower lobe consolidation. Sputum Gram stain shows gram-positive cocci in pairs. Which of the following is the most likely causative organism and the most appropriate initial antibiotic therapy? A) Mycoplasma pneumoniae; Azithromycin B) Streptococcus pneumoniae; Ceftriaxone and Azithromycin C) Legionella pneumophila; Levofloxacin D) Staphylococcus aureus; Vancomycin
Answer: B Explanation: The Gram stain suggests Streptococcus pneumoniae. The appropriate initial therapy for inpatient CAP is a beta-lactam (Ceftriaxone) combined with a macrolide (Azithromycin).
❌ Mistake 1: Prescribing macrolides as monotherapy in areas with high macrolide resistance for Streptococcus pneumoniae. ✅ How to avoid: Be aware of local resistance patterns and consider alternative antibiotics or combination therapy.
❌ Mistake 2: Forgetting to consider atypical pathogens in patients with pneumonia, especially in younger adults. ✅ How to avoid: If the patient has atypical symptoms (e.g., dry cough, extrapulmonary symptoms), consider covering for atypical pathogens with a macrolide or doxycycline.
Create a table summarizing the common pathogens and antibiotic treatments for different types of pneumonia (CAP, HAP, VAP, aspiration pneumonia).
What this chapter covers: This chapter covers a range of additional respiratory conditions and related pharmacological interventions, including antihistamines, decongestants, cell wall synthesis inhibitors, protein synthesis inhibitors, antifungal agents, and treatments for lung cancer. It aims to provide a comprehensive overview of these diverse topics.
| Drug/Class | Mechanism | Uses | Side Effects |
|---|---|---|---|
| Diphenhydramine | First-generation antihistamine; H1 receptor antagonist. | Allergic rhinitis, urticaria | Sedation, anticholinergic effects |
| Cetirizine | Second-generation antihistamine; H1 receptor antagonist. | Allergic rhinitis, urticaria | Less sedating than first-generation antihistamines |
| Pseudoephedrine | Alpha-1 adrenergic agonist; vasoconstriction of nasal mucosa. | Nasal congestion | Hypertension, tachycardia |
| Vancomycin | Glycopeptide antibiotic; binds to D-Ala-D-Ala, inhibiting cell wall synthesis. | MRSA infections | Nephrotoxicity, ototoxicity, Red Man Syndrome |
| Azithromycin | Macrolide antibiotic; blocks peptide exit tunnel, inhibiting protein synthesis. | Community-acquired pneumonia, atypical infections | QT prolongation, gastrointestinal upset |
| Fluconazole | Azole antifungal; inhibits fungal cytochrome P450, blocking ergosterol synthesis. | Candidiasis, cryptococcal meningitis | Hepatotoxicity, QT prolongation |
| Nivolumab | Anti-PD-1 antibody; blocks PD-1 receptor, enhancing T-cell activity against cancer cells. | Lung cancer | Immune-related adverse events (e.g., pneumonitis, colitis) |
Question: A 24-year-old female presents with nasal congestion and rhinorrhea. She is looking for an over-the-counter medication to relieve her symptoms. Which of the following medications is most likely to cause drowsiness? A) Cetirizine B) Loratadine C) Diphenhydramine D) Fexofenadine
Answer: C Explanation: Diphenhydramine is a first-generation antihistamine that readily crosses the blood-brain barrier, causing significant sedation. Second-generation antihistamines (cetirizine, loratadine, fexofenadine) are less likely to cause drowsiness.
❌ Mistake 1: Prescribing first-generation antihistamines to elderly patients due to the increased risk of anticholinergic side effects. ✅ How to avoid: Use second-generation antihistamines in elderly patients whenever possible.
❌ Mistake 2: Not adjusting vancomycin dosing based on serum levels, leading to subtherapeutic or toxic levels. ✅ How to avoid: Monitor vancomycin trough levels and adjust the dose accordingly to maintain therapeutic levels and minimize the risk of nephrotoxicity and ototoxicity.
Create flashcards for each antibiotic, antifungal, and chemotherapeutic agent, including their mechanism of action, spectrum of activity, common uses, and important side effects.
Create a free account to import and read the full study notes — all 4 sections.
No credit card · 2 free imports included